Clinical Report: Triphenyl Phosphate Induces Lipid Accumulation in Human Mesenchymal Stem Cells

Overview

This report discusses the effects of Triphenyl Phosphate (TPhP) on lipid accumulation in human mesenchymal stem cells, highlighting its role in metabolic stress mechanisms. The findings suggest potential implications for metabolic health due to chronic exposure to TPhP.

Background

Triphenyl Phosphate (TPhP) is a prevalent organophosphate flame retardant found in various consumer products, raising concerns about its chronic exposure effects on human health. Evidence links TPhP to adverse outcomes such as neurotoxicity, developmental toxicity, and metabolic disorders. Understanding TPhP's impact on lipid metabolism is crucial given the rising prevalence of obesity and metabolic diseases globally.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

• TPhP exposure leads to significant lipid accumulation in human mesenchymal stem cells.
• The mechanism of lipid accumulation is associated with metabolic stress pathways.
• Chronic exposure to TPhP may disrupt normal metabolic processes, contributing to obesity and metabolic disorders.
• Environmental presence of TPhP raises concerns about its long-term health impacts.
• In vivo studies indicate that TPhP exposure affects growth rates and hepatic protein profiles in animal models.

Clinical Implications

Clinicians should be aware of the potential metabolic risks associated with TPhP exposure, particularly in vulnerable populations. Monitoring and understanding the implications of endocrine-disrupting chemicals like TPhP is essential for addressing metabolic health concerns.

Conclusion

The findings on TPhP's role in lipid accumulation underscore the need for further research into its health impacts, particularly regarding metabolic disorders. Ongoing evaluation of exposure risks is critical for public health.

Related Resources & Content

1. Archives of Toxicology, 2026 -- Triphenyl phosphate promotes lipid accumulation in human mesenchymal stem cells through metabolic stress pathways
2. Endocrine Society -- Endocrine-Disrupting Chemicals
3. the analytical scientist — Low-Dose PFAS Exposure Alters Cellular Metabolism 
4. Journal of Crohn's and Colitis — Lysophosphatidylcholine-induced aberrant adipogenesis in mesenchymal stem cells and impaired antibacterial function in adipocytes of creeping fat
5. Archives of Toxicology — Analyzing Phosphoproteomics to Explore Cellular Reactions to Chemical Stressors with Varied Mechanisms of Action
6. Journal of Gastroenterology — Pathways Leading to Triglyceride Build-Up in Non-Alcoholic Fatty Liver Disease
7. Low-Dose PFAS Exposure Alters Cellular Metabolism
8. Lysophosphatidylcholine-induced aberrant adipogenesis in mesenchymal stem cells
9. Endocrine-Disrupting Chemicals | Endocrine Society
10. Triphenyl phosphate promotes lipid accumulation in human mesenchymal stem cells through metabolic stress pathways | Archives of Toxicology | Springer Nature Link